Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/1996
12/17/1996US5585351 T-cadherin adhesion molecule
12/17/1996US5585347 Measuring prolactin level in blood at spaced intervals during subjects waking and sleeping periods over twenty four hours to create a profile; comparing to control
12/17/1996US5585344 Liver-derived receptors for advanced glycosylation endproducts and uses thereof
12/17/1996US5585279 Immunoassays
12/17/1996US5585278 Specific covalent bonding of antibody moieties to active functional groups on surface of hydrophobic shells of latex particles yields storage stable aqueous dispersion for sensitive accurate testing
12/17/1996US5585277 Determining ability of test ligands to increase the ratio of folded target protein to unfolded target protein; testing for possible pharmaceutical effectiveness
12/17/1996US5585276 Medium and method for blotting macromolecules
12/17/1996US5585274 Method for measuring β-glucan
12/17/1996US5585265 Transforming cells by using viral vectors, then culturing and recovering, genetic engineering
12/17/1996US5585264 Useful in vaccines to prevent disease in cattle
12/17/1996US5585262 Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus
12/17/1996US5585249 Polyhydroxybutyrate and polyphosphate membranes with channels
12/17/1996US5585248 Method for assaying activity of prophenoloxidase activating enzyme and application thereof
12/17/1996US5585246 Method for preparing a sample in a scan capillary for immunofluorescent interrogation
12/17/1996US5585245 Protein complex
12/17/1996US5585243 Method of detecting cytopenia that is mediated by drug-dependent antibody binding to blood cells
12/17/1996US5585241 Method of assay
12/17/1996US5585239 Herpes simplex virus drug screen
12/17/1996US5585236 Ion-pair reverse phase chromatography
12/17/1996US5585235 Fluorescent assay and method that corrects for spectral interference
12/17/1996US5585233 Mutant; gebnetic engineering
12/17/1996US5585232 Methods and diagnostic kits for determining toxicity utilizing E. coli stress promoters fused to reporter genes
12/17/1996US5585100 Vaccine; diagnosis, therapy and prevention of disease
12/17/1996US5585087 Assay for identifying extracellular signaling proteins
12/17/1996US5585069 Substrates with wells connected by channels controlled by valves, for concurrent analysis of several liquid samples
12/17/1996US5584978 Collection electrode (collectrode) for geo-electrochemical sampling
12/17/1996US5584790 Variable inclination centrifugation assembly for rapid separation of blood
12/17/1996US5584578 Drop-in immersion probe
12/17/1996CA2068190C Methods and compositions for enzyme complementation assays using the omega region of beta-galactosidase
12/17/1996CA2006684C Monoclonal antibody against protein c
12/17/1996CA1338800C Hepatitis delta and diagnostics and vaccines
12/16/1996WO1996039508A1 Fibroblast growth factor 13
12/16/1996CA2220988A1 Fibroblast growth factor 13
12/12/1996WO1996039631A1 METHOD OF IDENTIFYING PERSONS SUSCEPTIBLE TO GROUP A β-HEMOLYTIC STREPTOCOCCI-MEDIATED NEUROPSYCHIATRIC DISORDERS
12/12/1996WO1996039630A1 Detection of htlv antibodies utilizing recombinant proteins
12/12/1996WO1996039629A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/12/1996WO1996039628A1 GLYCOPROTEIN gp105 ON BL3 HEMATOPOIETIC STEM CELLS
12/12/1996WO1996039623A1 Monitoring of resistance in polymers
12/12/1996WO1996039618A1 Determining erythrocyte sedimentation rate and hematocrit
12/12/1996WO1996039542A1 Cultured cell line that inducibly expresses the hepatitis b virus genome, and uses thereof for screening antiviral substances
12/12/1996WO1996039541A1 Colon specific gene and protein
12/12/1996WO1996039534A1 Electrochemiluminescent enzyme biosensors
12/12/1996WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996WO1996039515A1 Human vascular endothelial growth factor 2
12/12/1996WO1996039513A2 Ebnerin cloning of a secreted von ebner's gland protein
12/12/1996WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
12/12/1996WO1996039504A2 Methods for distinguishing metastatic and non-metastatic cancers, polynucleotides and polypeptides for use therein
12/12/1996WO1996039503A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION
12/12/1996WO1996039497A1 Transforming growth factor alpha hi
12/12/1996WO1996039492A1 Reducing tyramine interference in (met)amphetamine immunoassays
12/12/1996WO1996039485A1 Human hepatoma-derived growth factor-2
12/12/1996WO1996039482A1 Compact blood culture apparatus
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039439A1 Human g-protein receptor hcegh45
12/12/1996WO1996039437A1 Human g-protein chemokine receptor hdgnr10
12/12/1996WO1996039434A1 Human g-protein receptor hgber32
12/12/1996WO1996039426A1 Hypoxia inducible factor-1 and method of use
12/12/1996WO1996039420A1 Human criptin growth factor
12/12/1996WO1996039417A1 Chemical, biochemical and biological processing in thin films
12/12/1996WO1996039372A2 Macrophage lipid chemoattractant
12/12/1996WO1996039186A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits
12/12/1996WO1996039185A1 Treatment and diagnosis of prostate cancer
12/12/1996WO1996039161A1 Multi-tyrosinated somatostatin analogs
12/12/1996WO1996039129A1 Methods of increasing amyloid deposition
12/12/1996WO1996024837A3 Spectrophotometric method and apparatus for the characterization of blood, blood types, and other bodily fluids
12/12/1996DE19521290A1 Test strip for urine analysis
12/12/1996DE19521181A1 Appts. which determines toxicity of water
12/12/1996DE19520729A1 Testsystem zur Erfassung der Aktivität von NK-Zellen Test system for detection of the activity of NK-cells
12/12/1996DE19520480A1 Enzyme immunoassay kit for diagnosis of coeliac disease
12/12/1996DE19520398A1 Magnetic particles with, opt. porous, glass surface
12/12/1996CA2562211A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2562162A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223733A1 Human hepatoma-derived growth factor-2
12/12/1996CA2223496A1 Chemical, biochemical and biological processing in thin films
12/12/1996CA2223439A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits
12/12/1996CA2223291A1 Treatment and diagnosis of prostate cancer
12/12/1996CA2223235A1 Detection of htlv antibodies utilizing recombinant proteins
12/12/1996CA2223100A1 Determining erythrocyte sedimentation rate and hematocrit
12/12/1996CA2223084A1 Monitoring of resistance in polymers
12/12/1996CA2223038A1 A c5a-like seven transmembrane receptor
12/12/1996CA2223017A1 Electrochemiluminescent enzyme biosensors
12/12/1996CA2222962A1 Multi-tyrosinated somatostatin analogs
12/12/1996CA2222737A1 Method of identifying persons susceptible to group a .beta.-hemolytic streptococci-mediated neuropsychiatric disorders
12/12/1996CA2222643A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/12/1996CA2222522A1 Glycoprotein gp105 on bl3 hematopoietic stem cells
12/12/1996CA2222280A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996CA2222040A1 Macrophage lipid chemoattractant
12/12/1996CA2221795A1 Colon specific gene and protein
12/12/1996CA2221706A1 G-protein receptor htnad29
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/12/1996CA2221274A1 Human g-protein receptor hgber32
12/12/1996CA2219447A1 Methods of increasing amyloid deposition
12/12/1996CA2217229A1 Pineal gland specific gene-1
12/12/1996CA2217216A1 Human chemokine beta-13
12/12/1996CA2216912A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2215286A1 Human criptin growth factor
12/11/1996EP0747708A2 Slide test element holder with minimized Z-axis variability
12/11/1996EP0747707A1 Propoxyphene derivatives for immunoassay reagents
12/11/1996EP0747706A1 Adduct protection assay